Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart drug joins fight against tough bladder cancer

NCT ID NCT07353294

Summary

This early-stage study is testing whether adding a common blood pressure medication (propranolol) to a standard pre-surgery treatment can improve outcomes for bladder cancer that has spread to lymph nodes. Twelve patients will receive the drug combination before having surgery to remove their cancer. The main goal is to check if this new combination is safe, while also seeing if it helps eliminate more cancer before surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER UROTHELIAL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.